Tyche Industries [TYCHE] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Tyche Industries Ltd.

BSE
Loading...

Sun Pharma Advanced Research Company Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Tyche Industries Ltd. wins in 13 metrics, Sun Pharma Advanced Research Company Ltd. wins in 4 metrics, with 1 ties. Tyche Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Tyche Industries Ltd. Sun Pharma Advanced Research Company Ltd. Better
P/E Ratio (TTM) 18.41 -13.65 Tyche Industries Ltd.
Price-to-Book Ratio 0.89 -13.55 Tyche Industries Ltd.
Debt-to-Equity Ratio 0.00 -1.21 Tie
PEG Ratio -0.30 -11.15 Tyche Industries Ltd.
EV/EBITDA 27.30 -22.27 Tyche Industries Ltd.
Profit Margin (TTM) 13.29% -53.22% Tyche Industries Ltd.
Operating Margin (TTM) 5.74% -700.71% Tyche Industries Ltd.
EBITDA Margin (TTM) 5.74% N/A N/A
Return on Equity 9.08% 157.88% Sun Pharma Advanced Research Company Ltd.
Return on Assets (TTM) 8.42% -102.08% Tyche Industries Ltd.
Free Cash Flow (TTM) $78.21M $-3.71B Tyche Industries Ltd.
Dividend Yield 3.84% N/A N/A
1-Year Return -1.94% 14.56% Sun Pharma Advanced Research Company Ltd.
Price-to-Sales Ratio (TTM) 2.48 87.98 Tyche Industries Ltd.
Enterprise Value $982.33M $50.87B Sun Pharma Advanced Research Company Ltd.
EV/Revenue Ratio 1.94 95.73 Tyche Industries Ltd.
Gross Profit Margin (TTM) 75.49% -59.53% Tyche Industries Ltd.
Revenue per Share (TTM) $49 $2 Tyche Industries Ltd.
Earnings per Share (Diluted) $6.65 $-8.25 Tyche Industries Ltd.
Beta (Stock Volatility) 0.29 0.19 Sun Pharma Advanced Research Company Ltd.

Tyche Industries Ltd. vs Sun Pharma Advanced Research Company Ltd. Stock Performance Analysis

Loading Price Chart...

TYCHE
SPARC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Tyche Industries Ltd.-3.99%2.38%13.22%24.81%14.30%19.30%
Sun Pharma Advanced Research Company Ltd.2.09%-13.30%46.20%62.20%26.84%51.26%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Tyche Industries Ltd.-1.94%-23.36%-37.49%133.45%913.33%436.47%
Sun Pharma Advanced Research Company Ltd.14.56%13.10%-5.14%-23.02%148.11%-27.03%

Performance & Financial Health Analysis: Tyche Industries Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricTYCHESPARC
Market Information
Market Cap i₹1.25B₹46.75B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i5,3142,401,062
90 Day Avg. Volume i8,8832,083,443
Last Close₹132.35₹208.50
52 Week Range₹99.00 - ₹148.80₹108.00 - ₹248.75
% from 52W High-11.06%-16.18%
All-Time High₹349.90 (Aug 17, 2020)₹875.00 (Apr 24, 2006)
% from All-Time High-62.17%-76.17%
Growth Metrics
Quarterly Revenue Growth-0.40%-0.43%
Quarterly Earnings Growth-0.62%-0.43%
Financial Health
Profit Margin (TTM) i0.13%-0.53%
Operating Margin (TTM) i0.06%-7.01%
Return on Equity (TTM) i0.09%1.58%
Debt to Equity (MRQ) i0.00-1.21
Cash & Liquidity
Book Value per Share (MRQ)₹137.61₹-10.63
Cash per Share (MRQ)₹26.45₹0.03
Operating Cash Flow (TTM) i₹112.96M₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹124.07M₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield i3.84%N/A
Last 12-Month Dividend i₹5.50N/A

Valuation & Enterprise Metrics Analysis: Tyche Industries Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricTYCHE (Apr 26, 2026)SPARC (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i18.41-13.65
Forward P/E i21.182.60
PEG Ratio i-0.30-11.15
Price to Sales (TTM) i2.4887.98
Price to Book (MRQ) i0.89-13.55
Market Capitalization
Market Capitalization i₹1.25B₹46.75B
Enterprise Value i₹982.33M₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i1.9495.73
Enterprise to EBITDA i27.30-22.27
Risk & Other Metrics
Beta i0.290.19
Book Value per Share (MRQ) i₹137.61₹-10.63

Financial Statements Comparison: Tyche Industries Ltd. vs Sun Pharma Advanced Research Company Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTYCHE (2025)SPARC (2025)
Revenue/Sales i654.71M717.66M
Cost of Goods Sold i363.99M1.10B
COGS % of Revenue i55.6%153.2%
Gross Profit i290.72M-381.94M
Gross Margin i44.4%-53.2%
Research & Development iN/AN/A
Operating Income (EBIT) i100.29M-3.34B
Operating Margin i15.3%-465.5%
EBITDA i186.80M-3.23B
EBITDA Margin i28.5%-450.0%
Pre-Tax Income i167.14M-3.43B
Pre-Tax Income % of Revenue i25.5%-477.6%
Income Tax i43.07M-2.72M
Income Tax % of Revenue i6.6%-0.4%
Net Income (Profit) i124.07M-3.43B
Profit Margin i19.0%-477.3%

Balance Sheet & Liquidity Metrics

MetricTYCHE (2025)SPARC (2025)
Cash & Equivalents i39.77M19.64M
Total Current Assets i1.21B261.97M
Total Current Assets % of Revenue i184.7%36.5%
Total Current Liabilities i96.25M3.74B
Total Current Liabilities % of Revenue i14.7%521.5%
Long-Term Debt i01.07B
Long-Term Debt % of Revenue i0.0%149.0%
Total Shareholders Equity i1.37B-2.17B
Retained Earnings i1.19B-23.22B
Retained Earnings % of Revenue i181.5%-3,235.0%
Property, Plant & Equipment i68.16M178.02M

Cash Flow Statement Comparison

MetricTYCHE (2025)SPARC (2025)
Operating Cash Flow i112.96M-3.48B
Operating Cash Flow % of Revenue i17.3%-485.5%
Capital Expenditures i-7.23M-97.45M
Free Cash Flow i78.21M-3.71B
FCF Margin i11.9%-516.4%
Debt Repayment iN/A-3.69B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTYCHESPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i10.25M324.52M
Float Shares i2.93M91.32M
% Held by Insiders i71.44%72.96%
% Held by Institutions i0.00%2.56%
% Held by Public i28.56%24.48%

Dividend Analysis & Yield Comparison: Tyche Industries Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricTYCHESPARC
Last 12-Month Dividend i₹5.50N/A
Last 12-Month Dividend Yield i3.84%N/A
3-Year Avg Annual Dividend i₹3.00N/A
3-Year Avg Dividend Yield i1.41%N/A
3-Year Total Dividends i₹9.00N/A
Ex-Dividend DateSep 19, 2025N/A